Laboratory Studies

Complete blood count, chemistry, creatine kinase, thyroid testing group, sedimentation rate, Lyme titer, Venereal Disease Research Laboratory (VDRL) test, and rheumatology screening are the basic laboratory tests for all patients with clinical myokymia. Serum alcohol level and toxic screen are recommended for acute onset of generalized myokymia.

Imaging Studies

Neuroimaging studies with CT scan or MRI usually are performed for certain regions after careful examination and in cases in which electrodiagnostic studies have localized a lesion to a particular area. For example, if facial myokymia is confirmed, MRI study of the brain with special attention to posterior fossa is ordered to search for an anatomic lesion. Imaging studies are not otherwise necessary for establishing the diagnosis of myokymia.

Other Tests

Nerve conduction velocity (NCV) and EMG studies are necessary to qualify and quantify neurogenic/myogenic dysfunction.

NCV can detect the presence of plexopathy, mononeuropathy, and polyneuropathy (axonal or demyelinating).
EMG can confirm the presence of myokymic discharges or neuromyotonia. The specific findings of myokymia in EMG examination are detailed in the Physical section.
EMG study also can document the presence of neurogenic/myogenic dysfunction and its distribution.
Information obtained through these studies serves as a guide for further diagnostic investigation. Serial studies can objectively document the evolution of the myokymia.

Procedures

Lumbar puncture with examination of cerebrospinal fluid (CSF) usually is performed for patients with documented acute or chronic polyradiculoneuropathy, central nervous system demyelinating disorder, or other suspected inflammatory, infectious, or neoplastic processes.

Treatment & Management

Schultze F. Beitrage zur Muskelpathologie. Deutsch Z Nervenheilk. 1895. 6:65-167.
Kny E. Ueber ein dem Paramyoclonus multiplex (Friedreich) nahestehendes Krankheitsbild. Arch Psychiat Nervenkr. 1888. 19:577.
Jackson DL, Satya-Murti S, Davis L, Drachman DB. Isaacs syndrome with laryngeal involvement: an unusual presentation of myokymia. Neurology. 1979 Dec. 29(12):1612-5. [QxMD MEDLINE Link].
Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiat. 1961. 24:319-325.
Doi H, Arimura K, Ohyagi Y, Kira J. Frostbite-like skin lesion as an autonomic symptom of Isaacs' syndrome. Intern Med. 2011. 50(10):1113-5. [QxMD MEDLINE Link].
Hayashi Y, Kimura A, Watanabe N, Yamada M, Sakurai T, Tanaka Y, et al. Serial monitoring of basal metabolic rate for therapeutic evaluation in an Isaacs' syndrome patient with chronic fluctuating symptoms. Intern Med. 2010. 49(5):475-7. [QxMD MEDLINE Link].
Lide B, Singh J, Haeri S. Isaacs' syndrome in pregnancy. BMJ Case Rep. 2014 Oct 9. 2014:[QxMD MEDLINE Link].
Daube JR, Kelly JJ, Martin RA. Facial myokymia with polyradiculoneuropathy. Neurology. 1979 May. 29(5):662-9. [QxMD MEDLINE Link].
Moghimi N, Rosen JB, Jabbari B. Ten Years' Follow-Up of a Family With Myokymia and Muscle Cramps Without Ataxia. J Child Neurol. 2013 Nov. 28(11):1493-1495. [QxMD MEDLINE Link].
Alapati A, Glaussen G, Oh SJ. Myokymia as an initial and predominant manifestation of dermatomyositis. AAEM Abstracts. 1999. 95.
Albers JW, Allen AA, Bastron JA, Daube JR. Limb myokymia. Muscle Nerve. 1981 Nov-Dec. 4(6):494-504. [QxMD MEDLINE Link].
Andermann F, Cosgrove J, Lloyd-Smith DL. Facial myokymia in multiple sclerosis. Brain. 1961. 84:31-44.
Blunt SB, Khalil NM, Perkin GD. Facial myokymia in multiple system atrophy. Mov Disord. 1997 Mar. 12(2):235-8. [QxMD MEDLINE Link].
Brick JF, Gutmann L, McComas CF. Calcium effect on generation and amplification of myokymic discharges. Neurology. 1982 Jun. 32(6):618-22. [QxMD MEDLINE Link].
Chinskey ND, Cornblath WT. Inferior oblique myokymia: a unique ocular motility disorder. JAMA Ophthalmol. 2013 Mar. 131(3):404-5. [QxMD MEDLINE Link].
Denny-Brown D, Foley JM. Myokymia and the benign fasciculation of muscular cramps. Trans Assoc Am Physicians. 1948. 61:88-96.
Fernandez M, Raskind W, Wolff J, Matsushita M, Yuen E, Graf W. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol. 2001 Apr. 49(4):486-92. [QxMD MEDLINE Link].
Gardner-Medwin D, Walton JN. Myokymia with impaired muscular relaxation. Lancet. 1969 Jan 18. 1(7586):127-30. [QxMD MEDLINE Link].
Greenhouse AH, Bicknell JM, Pesch RN, Seelinger DF. Myotonia, myokymia, hyperhidrois and wasting of muscle. Neurology. 1967 Mar. 17(3):263-8. [QxMD MEDLINE Link].
Gutmann L, Gutmann L. Myokymia and neuromyotonia 2004. J Neurol. 2004 Feb. 251(2):138-42. [QxMD MEDLINE Link].
Hudson AJ, Brown WF, Gilbert JJ. The muscular pain-fasciculation syndrome. Neurology. 1978 Nov. 28(11):1105-9. [QxMD MEDLINE Link].
Isaacs H. Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality. J Neurol Neurosurg Psychiatry. 1967 Apr. 30(2):126-33. [QxMD MEDLINE Link].
Isaacs H, Frere G. Syndrome of continuous muscle fibre activity. Histochemical, nerve terminal and end-plate study of two cases. S Afr Med J. 1974 Aug 10. 48(38):1601-7. [QxMD MEDLINE Link].
Lance JW, Burke D, Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol. 1979 Jun. 5(6):523-32. [QxMD MEDLINE Link].
Lublin FD, Tsairis P, Streletz LJ, et al. Myokymia and impaired muscular relaxation with continuous motor unit activity. J Neurol Neurosurg Psychiatry. 1979 Jun. 42(6):557-62. [QxMD MEDLINE Link].
Lutschg J, Jerusalem F, Ludin HP, et al. The syndrome of 'continuous muscle fiber activity.'. Arch Neurol. 1978 Apr. 35(4):198-205. [QxMD MEDLINE Link].
Matthews WB. Facial myokymia. J Neurol Neurosurg Psychiatry. 1966 Feb. 29(1):35-9. [QxMD MEDLINE Link].
Medina JL, Chokroverty S, Reyes M. Localized myokymia caused by peripheral nerve injury. Arch Neurol. 1976 Aug. 33(8):587-8. [QxMD MEDLINE Link].
Parry-Jones NO, Stephens JA, Taylor A, Yates DA. Myokymia, not myotonia. Br Med J. 1977 Jul 30. 2(6082):300. [QxMD MEDLINE Link].
Roth G. The origin of fasciculations. Ann Neurol. 1982 Dec. 12(6):542-7. [QxMD MEDLINE Link].
Solimena M, Folli F, Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med. 1988 Apr 21. 318(16):1012-20. [QxMD MEDLINE Link].
Valenstein E, Watson RT, Parker JL. Myokymia, muscle hypertrophy and percussion "myotonia" in chronic recurrent polyneuropathy. Neurology. 1978 Nov. 28(11):1130-4. [QxMD MEDLINE Link].
Wallis WE, Van Poznak A, Plum F. Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol. 1970 May. 22(5):430-9. [QxMD MEDLINE Link].
Welch LK, Appenzeller O, Bicknell JM. Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity. Neurology. 1972 Feb. 22(2):161-9. [QxMD MEDLINE Link].
Williamson E, Brooke MH. Myokymia and the motor unit. A histochemical study. Arch Neurol. 1972 Jan. 26(1):11-6. [QxMD MEDLINE Link].

Media Gallery

of 0

Author

Suying L Song, MD Assistant Clinical Professor of Neurology, New York University School of Medicine

Suying L Song, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Neil A Busis, MD Chief of Neurology and Director of Neurodiagnostic Laboratory, UPMC Shadyside; Clinical Professor of Neurology and Director of Community Neurology, Department of Neurology, University of Pittsburgh Physicians

Neil A Busis, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: American Academy of Neurology<br/>Serve(d) as a speaker or a member of a speakers bureau for: American Academy of Neurology<br/>Received income in an amount equal to or greater than $250 from: American Academy of Neurology.

Chief Editor

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL Co-Founder and Former Chief Publishing Officer, eMedicine and eMedicine Health, Founding Editor-in-Chief, eMedicine Neurology; Founder and Former Chairman and CEO, Pearlsreview; Founder and CEO/CMO, PHLT Consultants; Former Chief Medical Officer, MeMD Inc

Nicholas Lorenzo, MD, CPE, MHCM, FAAPL is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Association for Physician Leadership

Disclosure: Nothing to disclose.

Additional Contributors

Carmel Armon, MD, MSc, MHS Chair, Department of Neurology, Assaf Harofeh Medical Center, Tel Aviv University Sackler Faculty of Medicine, Israel

Carmel Armon, MD, MSc, MHS is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American College of Physicians, American Epilepsy Society, American Medical Association, American Neurological Association, American Stroke Association, Massachusetts Medical Society, Sigma Xi, The Scientific Research Honor Society

Disclosure: Received research grant from: Neuronix Ltd, Yoqnea'm, Israel<br/>Received income in an amount equal to or greater than $250 from: JNS - Associate Editor. UpToDate - Author Royalties.